SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-16-000575
Filing Date
2016-05-06
Accepted
2016-05-06 16:35:32
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2013526
2 g178708.jpg GRAPHIC 65596
3 g194287.jpg GRAPHIC 206420
4 g248340.jpg GRAPHIC 54773
5 g256830.jpg GRAPHIC 81517
6 g379956.jpg GRAPHIC 101805
7 g454073.jpg GRAPHIC 27830
8 g668517.jpg GRAPHIC 186127
9 g766537.jpg GRAPHIC 120862
10 g799768.jpg GRAPHIC 83640
11 g823840.jpg GRAPHIC 15173
12 g888392.jpg GRAPHIC 85704
  Complete submission text file 0000912057-16-000575.txt   3433663
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01321 | Film No.: 161628598
SIC: 2834 Pharmaceutical Preparations